Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 24 citing articles:

Effect of Risk Mitigation Guidance for opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study
Amanda Slaunwhite, Jeong Eun Min, Heather Palis, et al.
BMJ (2024), pp. e076336-e076336
Open Access | Times Cited: 48
Prescribed safer opioid supply: A scoping review of the evidence
Shaleesa Ledlie, Ria Garg, Clare Cheng, et al.
International Journal of Drug Policy (2024) Vol. 125, pp. 104339-104339
Open Access | Times Cited: 28
Letter to the Editor re Kahan M. Effectiveness and Public Health Impact of Safer Supply and Opioid Agonist Treatment: A Narrative Review With Recommendations
Patty Wilson, Tara Gomes, Adrian Guţă, et al.
The Canadian Journal of Addiction (2025) Vol. 16, Iss. 1, pp. 45-46
Closed Access | Times Cited: 1
Law Enforcement Drug Seizures and Opioid-Involved Overdose Mortality
Alex H. Kral, Jamie L. Humphrey, Clyde Schwab, et al.
JAMA Network Open (2025) Vol. 8, Iss. 3, pp. e251158-e251158
Open Access | Times Cited: 1
Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis
Mohammad Karamouzian, Bijan Rafat, Gillian Kolla, et al.
International Journal of Drug Policy (2023) Vol. 120, pp. 104157-104157
Open Access | Times Cited: 22
Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes
Geoff Bardwell, Andrew Ivsins, Manal Mansoor, et al.
Canadian Medical Association Journal (2023) Vol. 195, Iss. 19, pp. E668-E676
Open Access | Times Cited: 17
‘I don't chase drugs as much anymore, and I'm not dead’: Client reported outcomes associated with safer opioid supply programs in Ontario, Canada
Rose A. Schmidt, Nat Kaminski, David T. Kryszajtys, et al.
Drug and Alcohol Review (2023) Vol. 42, Iss. 7, pp. 1825-1837
Open Access | Times Cited: 17
Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies
Karen Giang, Reith Charlesworth, Madison Thulien, et al.
International Journal of Drug Policy (2023) Vol. 115, pp. 104023-104023
Open Access | Times Cited: 14
Opioid medication doses among safer supply clients: Current safer supply doses and previous OAT experience
Gillian Kolla, Kaitlin Fajber, Andrea Sereda, et al.
Drug and Alcohol Dependence Reports (2025), pp. 100338-100338
Open Access
Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey
Heather Palis, Beth Haywood, Jenny McDougall, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Just have this come from their prescription pad: the medicalization of safer supply from the perspectives of health planners in BC, Canada
Celeste Macevicius, Daniel Gudiño Pérez, Alexa Norton, et al.
Drugs Education Prevention and Policy (2023), pp. 1-11
Closed Access | Times Cited: 8
“And this is the life jacket, the lifeline they’ve been wanting”: Participant perspectives on navigating challenges and successes of prescribed safer supply
Nancy Henderson, John Marris, Kirsten Woodend
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0299801-e0299801
Open Access | Times Cited: 2
Iteration is not solving the opioid crisis, it’s time for transformation
Kelly E. Dunn
The American Journal of Drug and Alcohol Abuse (2023) Vol. 49, Iss. 2, pp. 151-158
Closed Access | Times Cited: 4
Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project
Manal Mansoor, Annie Foreman-Mackey, Andrew Ivsins, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 4
Acceptability and anticipated effectiveness of a safe supply of opioids, among people who inject opioids in King County, WA
Adam Palayew, Caleb J. Banta‐Green, Malika Lamont, et al.
International Journal of Drug Policy (2024) Vol. 127, pp. 104389-104389
Closed Access | Times Cited: 1
Effectiveness and Public Health Impact of Safer Supply and Opioid Agonist Treatment: A Narrative Review with Recommendations
Meldon Kahan
The Canadian Journal of Addiction (2024) Vol. 15, Iss. 2, pp. 6-16
Open Access | Times Cited: 1
Preferred pharmaceutical-grade opioids to reduce the use of unregulated opioids: A cross-sectional analysis among people who use unregulated opioids in Vancouver, Canada
Kelsey A. Speed, JinCheol Choi, Guy Felicella, et al.
International Journal of Drug Policy (2024) Vol. 132, pp. 104564-104564
Open Access | Times Cited: 1
Opioid Use Disorder: Pernicious and Persistent
Cecilia L. Bergeria, Eric C. Strain
American Journal of Psychiatry (2022) Vol. 179, Iss. 10, pp. 708-714
Closed Access | Times Cited: 7
Treating people where they are: Nurse‐led micro‐elimination of hepatitis C in supported housing sites for networks of people who inject drugs in Victoria, Canada
Marion Selfridge, Tamara Barnett, Karen Lundgren, et al.
Public Health Nursing (2022) Vol. 39, Iss. 5, pp. 1009-1016
Closed Access | Times Cited: 5
Evaluation of audit and feedback to family physicians on prescribing of opioid analgesics to opioid-naïve patients: A pragmatic randomized delay trial
Rita McCracken, Shawna Narayan, Malcolm Maclure, et al.
Contemporary Clinical Trials (2023) Vol. 134, pp. 107354-107354
Open Access | Times Cited: 2
Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality
Chrianna Bharat, Natasa Gisev, Sebastiano Barbieri, et al.
International Journal of Drug Policy (2023) Vol. 123, pp. 104287-104287
Open Access | Times Cited: 2
Examining Safer Opioid Supply Policies—Reply
Hai V. Nguyen, Shweta Mital, Emma E. McGinty
JAMA Internal Medicine (2024) Vol. 184, Iss. 7, pp. 848-848
Closed Access
New and Expanding Populations of People Experiencing Homelessness in British Columbia, Canada During the COVID-19 Pandemic
Rana Van Tuyl, Michael Nayat Young
International Journal on Homelessness (2023), pp. 1-12
Open Access | Times Cited: 1
Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey
Heather Palis, Beth Haywood, Jenny McDougall, et al.
Research Square (Research Square) (2023)
Open Access
Commentary on Brothers et al.: The role of safer environment interventions in addressing injecting‐related bacterial and fungal infections
Will Small, Sean O’Callaghan
Addiction (2023) Vol. 118, Iss. 10, pp. 1878-1880
Open Access
Page 1

Scroll to top